Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Runlin Gao

Showing results (211-220 of 326) with videos related to

Pageof 33
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 30, 2020
Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery diseaseDeshan Yuan, Ce Zhang, Sida Jia, et al.
Journal of the American Society of Hypertension : JASH|August 27, 2018
Association between subjective sleep duration on workdays or non-workdays and uncontrolled blood pressure in Southern ChinaLihua Hu, Yihua Zhou, Xiao Huang, et al.
The American Journal of the Medical Sciences|June 24, 2019
Prognostic Significance of In-hospital Acquired Thrombocytopenia in Stable Coronary Artery Disease Undergoing Percutaneous Coronary InterventionPing Jiang, Zhan Gao, Wei Zhao, et al.
Clinical Cardiology|April 28, 2023
For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?-A 5-year follow-up cohort studyRu Liu, Haibo Liu, Deshan Yuan, et al.
Circulation|February 17, 2018
Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015Zengwu Wang, Zuo Chen, Linfeng Zhang, et al.
JAMA Cardiology|September 28, 2019
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled StudyGregg W Stone, Takeshi Kimura, Runlin Gao, et al.
Cardiovascular Diabetology|March 22, 2022
High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohortPeizhi Wang, Deshan Yuan, Ce Zhang, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Prognostic Value of Temporary Pacemaker Insertion in Patients with Acute Myocardial Infarction in the Era of Percutaneous Coronary RevascularizationPeng Wang, Shidong Wang, Zhimin Liu, et al.
Cardiovascular Diabetology|July 17, 2021
Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort studyDeshan Yuan, Ping Jiang, Pei Zhu, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males: Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled TrialsSatya Shreenivas, Dean J Kereiakes, Stephen G Ellis, et al.
Pageof 33

Showing results (211-220 of 326) with videos related to

Sort By:
Pageof 33
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 30, 2020
Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery diseaseDeshan Yuan, Ce Zhang, Sida Jia, et al.
Journal of the American Society of Hypertension : JASH|August 27, 2018
Association between subjective sleep duration on workdays or non-workdays and uncontrolled blood pressure in Southern ChinaLihua Hu, Yihua Zhou, Xiao Huang, et al.
The American Journal of the Medical Sciences|June 24, 2019
Prognostic Significance of In-hospital Acquired Thrombocytopenia in Stable Coronary Artery Disease Undergoing Percutaneous Coronary InterventionPing Jiang, Zhan Gao, Wei Zhao, et al.
Clinical Cardiology|April 28, 2023
For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?-A 5-year follow-up cohort studyRu Liu, Haibo Liu, Deshan Yuan, et al.
Circulation|February 17, 2018
Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015Zengwu Wang, Zuo Chen, Linfeng Zhang, et al.
JAMA Cardiology|September 28, 2019
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled StudyGregg W Stone, Takeshi Kimura, Runlin Gao, et al.
Cardiovascular Diabetology|March 22, 2022
High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohortPeizhi Wang, Deshan Yuan, Ce Zhang, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Prognostic Value of Temporary Pacemaker Insertion in Patients with Acute Myocardial Infarction in the Era of Percutaneous Coronary RevascularizationPeng Wang, Shidong Wang, Zhimin Liu, et al.
Cardiovascular Diabetology|July 17, 2021
Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort studyDeshan Yuan, Ping Jiang, Pei Zhu, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Efficacy and Safety of the Absorb Bioresorbable Vascular Scaffold in Females and Males: Results of an Individual Patient-Level Pooled Meta-Analysis of Randomized Controlled TrialsSatya Shreenivas, Dean J Kereiakes, Stephen G Ellis, et al.
Pageof 33